NextCure, Inc. Q1 2025 10-Q Filed
Ticker: NXTC · Form: 10-Q · Filed: May 1, 2025 · CIK: 1661059
| Field | Detail |
|---|---|
| Company | Nextcure, Inc. (NXTC) |
| Form Type | 10-Q |
| Filed Date | May 1, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, balance-sheet
TL;DR
NextCure's Q1 2025 10-Q shows assets of $28M vs liabilities of $27.9M.
AI Summary
NextCure, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported total assets of $28,006,684 and total liabilities of $27,903,040 as of March 31, 2025. This filing covers the first quarter of 2025, detailing the company's financial position and operational updates.
Why It Matters
This filing provides a snapshot of NextCure's financial health at the end of Q1 2025, crucial for investors assessing the company's stability and operational status.
Risk Assessment
Risk Level: medium — The company has very thin net assets, indicating a high degree of financial risk.
Key Numbers
- $28.01M — Total Assets (As of March 31, 2025)
- $27.90M — Total Liabilities (As of March 31, 2025)
Key Players & Entities
- NextCure, Inc. (company) — Filer of the 10-Q
- March 31, 2025 (date) — End of reporting period
- 20250331 (date) — Conformed period of report
- 28006684 (dollar_amount) — Total assets as of March 31, 2025
- 27903040 (dollar_amount) — Total liabilities as of March 31, 2025
FAQ
What was NextCure, Inc.'s net income or loss for the first quarter of 2025?
The provided excerpt does not contain specific net income or loss figures for the first quarter of 2025.
What are the main components of NextCure, Inc.'s current assets as of March 31, 2025?
The filing mentions 'PrepaidExpenseAndOtherAssetsCurrent' but does not detail its specific value or other current asset components.
Did NextCure, Inc. engage in any significant debt financing during the period ending March 31, 2025?
The provided excerpt does not contain information regarding debt financing activities.
What is the reported value of NextCure, Inc.'s common stock as of March 31, 2025?
The filing indicates 'us-gaap:CommonStockMember' but does not provide a specific dollar value for common stock as of March 31, 2025.
What was the retained earnings balance for NextCure, Inc. on March 31, 2025?
The retained earnings balance on March 31, 2025, is not explicitly stated in the provided excerpt, though balances for other dates are referenced.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 1, 2025 regarding NextCure, Inc. (NXTC).